Thymalin — Complete Research Guide (2026)
Last updated 2026-06-25
TL;DR
A thymus-derived polypeptide preparation studied in Russia for immunomodulatory effects in older adults.
What is Thymalin?
Thymalin is a polypeptide preparation extracted from calf thymus, developed largely by the Khavinson research group in Russia and studied for immunomodulation.
It is registered and used as a drug in Russia and some post-Soviet states but is not approved by the FDA or EMA; outside those markets it is treated as research-use-only.
Much of the supporting evidence comes from a single research group and from older or non-Western-registry studies, so the independent, high-quality evidence base is limited.
How does Thymalin work?
Thymalin is described as restoring or modulating immune function, including effects on T-cell populations and, in cell studies, differentiation of hematopoietic stem cells.
Its active dipeptide fragments (such as KE/EW) are proposed to influence gene expression relevant to immune regulation. [INFOGRAPHIC: Thymalin immunomodulation]
What does the research say about Thymalin?
- In cell-culture work, thymalin promoted differentiation of human hematopoietic stem cells. [1]
- In a controlled long-term clinical observation, thymic and pineal peptide bioregulators including thymalin were associated with reduced mortality in older adults (single-group data). [2]
- Thymalin has been used within complex therapy protocols for hospitalized COVID-19 patients in clinical reports. [3]
Clinical research & studies
The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.
- [1] Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells — Khavinson VK et al., Bull Exp Biol Med 2020. (in-vitro)
- [2] Peptides of pineal gland and thymus prolong human life — Khavinson VKh et al., Neuro Endocrinol Lett 2003. (human (single-group))
- [3] Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19 — Khavinson VK et al., Stem Cell Rev Rep 2021. (human)
- [4] The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19 — Linkova N et al., Int J Mol Sci 2023. (in-vitro)
- [5] Thymus and adaptive changes of bone marrow cell composition in animals of different age — Labunets IF et al., Adv Gerontol 2011. (animal)
Dosing context
Historical clinical use in its registered markets involved intramuscular courses, but these protocols are not validated by modern independent trials.
No standardized, regulator-backed dosing exists outside those markets, and research contexts do not establish a safe self-administration dose.
Side effects & safety profile
Independent, modern controlled safety data are limited, and most published safety experience comes from one research group and older studies.
As an animal-derived biological extract it carries theoretical risks (immunogenicity, contamination) that have not been characterized in rigorous Western trials.
It is not FDA- or EMA-approved, and material sold outside its registered markets should be treated as an unverified research compound.
Stacking & combinations
Older studies often paired thymalin with the pineal peptide epithalamin, but combination use is not supported by independent controlled evidence.
Finding Thymalin vendors
Finding Thymalin vendors
This is an independent, neutral directory — we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.
Choose your country
We never list placeholder vendors. Pick your country to see neutral regulatory context.
User reviews
No reviews yet
Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews — we never fabricate ratings.
Frequently asked questions
Thymalin is a polypeptide preparation extracted from calf thymus, studied mainly for immune-modulating effects.
References
- [1] Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells — Khavinson VK et al., Bull Exp Biol Med 2020. PMID: 33237528. View sourceStudy: in-vitroThymalin promoted differentiation of human hematopoietic stem cells in culture.
- [2] Peptides of pineal gland and thymus prolong human life — Khavinson VKh et al., Neuro Endocrinol Lett 2003. PMID: 14523363. View sourceStudy: human (single-group)Long-term administration of thymic (thymalin) and pineal peptide bioregulators was associated with lower mortality in older subjects in this single-group study.
- [3] Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19 — Khavinson VK et al., Stem Cell Rev Rep 2021. PMID: 33575961. View sourceStudy: humanReports use of thymalin within combination treatment of COVID-19 patients.
- [4] The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19 — Linkova N et al., Int J Mol Sci 2023. PMID: 37686182. View sourceStudy: in-vitroDipeptide components of thymalin altered expression of genes relevant to COVID-19 pathogenesis in a molecular study.
- [5] Thymus and adaptive changes of bone marrow cell composition in animals of different age — Labunets IF et al., Adv Gerontol 2011. PMID: 21957575. View sourceStudy: animalThymalin administration influenced bone-marrow cell precursor populations in mice of different ages.